Feb 21, 2023 | Comparative Effectiveness, Drug advertising, MedBen Rx, Research, TruDataRx
Drug companies spend $6 billion per year on direct-to-consumer ads with the goal of getting patients to ask their doctors to prescribe drugs that, in many instances, cost substantially more but are less effective than their current medications. And with no comparative...
Feb 20, 2023 | Consumer-driven Health Plans, Flexible spending accounts (FSAs), FSA Grace period, FSA Store
If your health plan offers a grace period for members to use any remaining 2022 flexible spending account (FSA) funds, you’ll want to remind them that those funds will no longer be available after March 15, 2023. Any claims submitted before that date will...
Feb 17, 2023 | Affordable Care Act, Birth Control, Compliance, News, Prescription
On February 2, 2023, the Departments of Labor, Health and Human Services, and Treasury (the “Tri-Agencies”) proposed a rule to expand women’s access to birth control under the Affordable Care Act (ACA). The proposed rule revises the exemption allowances...
Feb 16, 2023 | Cancer, MedBen WellLiving, Preventive Care, Research, Wellness, Wellness exam
Prevention and early detection have contributed to a three-decade decline in cancer mortality, a new report from the American Cancer Society (ACS) finds. With an increased emphasis on being proactive about wellness exams and cancer screenings, the U.S. cancer death...
Feb 15, 2023 | Compliance, Independent Dispute Resolution (IDR), Lawsuits, News, No Surprises Act (NSA), Regulatory
Independent Dispute Resolution (IDR) review decisions have been placed on hold due to a lawsuit brought forth by the Texas Medical Association (TMA). The lawsuit challenges the Final Rules of the No Surprises Act, specifically those relating to how the Qualified...
